Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Current Taxes: 2016-2022

  • Altimmune's Current Taxes was N/A to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2016, which is N/A change from last year.
  • Altimmune's Current Taxes amounted to $1.2 million in Q3 2022, which was down 62.98% from $3.2 million recorded in Q4 2016.
  • Altimmune's Current Taxes' 5-year high stood at $1.2 million during Q3 2022, with a 5-year trough of $1.2 million in Q3 2022.
  • Moreover, its 1-year median value for Current Taxes was $1.2 million (2022), whereas its average is $1.2 million.